<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/1999/REC-html401-19991224/loose.dtd">
<html><head><title>Details for gene set CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN[GSEA]</title><link href='xtools.css' rel='stylesheet'><link href='http://www.gsea-msigdb.org/gsea/images/icon_16x16.png' rel='shortcut icon'></head><body><div class='keyValTable'><table cols='2' border='0'><th class='keyValTable'></th><th class='keyValTable'></th><tr><td>Dataset</td><td>GSEA_formatted_DGE_counts_collapsed_to_symbols.sample_info.cls.txt<br>#nonresponse_versus_response.sample_info.cls.txt<br>#nonresponse_versus_response_repos</td></tr><tr><td>Phenotype</td><td>sample_info.cls.txt#nonresponse_versus_response_repos</td></tr><tr><td>Upregulated in class</td><td>0</td></tr><tr><td>GeneSet</td><td>CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN</td></tr><tr><td>Enrichment Score (ES)</td><td>0.48633763</td></tr><tr><td>Normalized Enrichment Score (NES)</td><td>1.0725027</td></tr><tr><td>Nominal p-value</td><td>0.46692607</td></tr><tr><td>FDR q-value</td><td>1.0</td></tr><tr><td>FWER p-Value</td><td>0.947</td></tr><caption class='table'>Table: GSEA Results Summary</caption></table></div><br><div class='image'><img name='enplot_CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN' src='enplot_CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN_45.png'><br><br><caption>Fig 1: Enrichment plot: CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN &nbsp&nbsp <br> Profile of the Running ES Score & Positions of GeneSet Members on the Rank Ordered List</caption></div><br><div class='richTable'><table cols='7' border='1'><th class='richTable'></th><th class='richTable'>SYMBOL</th><th class='richTable'>TITLE</th><th class='richTable'>RANK IN GENE LIST</th><th class='richTable'>RANK METRIC SCORE</th><th class='richTable'>RUNNING ES</th><th class='richTable'>CORE ENRICHMENT</th><tr><td class='lessen'>1</td><td><a href='https://ensembl.org/Search/Results?q=APCDD1L'>APCDD1L</a></td><td>APC down-regulated 1 like [Source:HGNC Symbol;Acc:HGNC:26892]</td><td>25</td><td>0.626</td><td>0.0343</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>2</td><td><a href='https://ensembl.org/Search/Results?q=INHBA'>INHBA</a></td><td>inhibin subunit beta A [Source:HGNC Symbol;Acc:HGNC:6066]</td><td>49</td><td>0.536</td><td>0.0590</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>3</td><td><a href='https://ensembl.org/Search/Results?q=CLMP'>CLMP</a></td><td>CXADR like membrane protein [Source:HGNC Symbol;Acc:HGNC:24039]</td><td>50</td><td>0.534</td><td>0.1514</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>4</td><td><a href='https://ensembl.org/Search/Results?q=DKK3'>DKK3</a></td><td>dickkopf WNT signaling pathway inhibitor 3 [Source:HGNC Symbol;Acc:HGNC:2893]</td><td>55</td><td>0.519</td><td>0.2293</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>5</td><td><a href='https://ensembl.org/Search/Results?q=LAYN'>LAYN</a></td><td>layilin [Source:HGNC Symbol;Acc:HGNC:29471]</td><td>70</td><td>0.500</td><td>0.2743</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>6</td><td><a href='https://ensembl.org/Search/Results?q=ADAMTS12'>ADAMTS12</a></td><td>ADAM metallopeptidase with thrombospondin type 1 motif 12 [Source:HGNC Symbol;Acc:HGNC:14605]</td><td>88</td><td>0.482</td><td>0.3073</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>7</td><td><a href='https://ensembl.org/Search/Results?q=COL13A1'>COL13A1</a></td><td>collagen type XIII alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2190]</td><td>128</td><td>0.413</td><td>0.2634</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>8</td><td><a href='https://ensembl.org/Search/Results?q=GFPT2'>GFPT2</a></td><td>glutamine-fructose-6-phosphate transaminase 2 [Source:HGNC Symbol;Acc:HGNC:4242]</td><td>135</td><td>0.397</td><td>0.3143</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>9</td><td><a href='https://ensembl.org/Search/Results?q=PXDN'>PXDN</a></td><td>peroxidasin [Source:HGNC Symbol;Acc:HGNC:14966]</td><td>137</td><td>0.396</td><td>0.3798</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>10</td><td><a href='https://ensembl.org/Search/Results?q=BCAT1'>BCAT1</a></td><td>branched chain amino acid transaminase 1 [Source:HGNC Symbol;Acc:HGNC:976]</td><td>146</td><td>0.384</td><td>0.4225</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>11</td><td><a href='https://ensembl.org/Search/Results?q=MRC2'>MRC2</a></td><td>mannose receptor C type 2 [Source:HGNC Symbol;Acc:HGNC:16875]</td><td>159</td><td>0.371</td><td>0.4512</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>12</td><td><a href='https://ensembl.org/Search/Results?q=MMP2'>MMP2</a></td><td>matrix metallopeptidase 2 [Source:HGNC Symbol;Acc:HGNC:7166]</td><td>169</td><td>0.357</td><td>0.4863</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>13</td><td><a href='https://ensembl.org/Search/Results?q=RAB31'>RAB31</a></td><td>RAB31, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:9771]</td><td>210</td><td>0.267</td><td>0.4142</td><td>No</td></tr><caption class='table'>Table: GSEA details&nbsp<a href='CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN.tsv'>[plain text format]</a></caption></table></div><br><div class='image'><img name='CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN' src='CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN_46.png'><br><br><caption>Fig 2: CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN &nbsp&nbsp <br> Blue-Pink O' Gram in the Space of the Analyzed GeneSet</caption></div><br><div class='image'><img name='gset_rnd_es_dist' src='gset_rnd_es_dist_47.png'><br><br><caption>Fig 3: CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN: Random ES distribution &nbsp&nbsp <br> Gene set null distribution of ES for <b>CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN</b></caption></div><br></body></html>